Cargando…

Weight loss in hypertrophic cardiomyopathy: A clinical case series

BACKGROUND: Obesity is prevalent among patients with hypertrophic cardiomyopathy (HCM). Obese HCM patients have greater wall thickness, LV mass, worse hemodynamic function and NYHA class. Weight loss may favorably influence the HCM phenotype. CASE SUMMARY: We describe six patients with hypertrophic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reuter, Maria C., Massera, Daniele, Axel, Leon, Latson, Larry A., Goldstein, Jonathan M., Stepanovic, Alexandra, Sherrid, Mark V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009201/ https://www.ncbi.nlm.nih.gov/pubmed/36923366 http://dx.doi.org/10.1016/j.ijcrp.2023.200179

Ejemplares similares

COVID-19 in Adults With Hypertrophic Cardiomyopathy
por: Arabadjian, Milla E., et al.
Publicado: (2021)

Clinical course and outcomes in adults with co-occurring hypertrophic cardiomyopathy and hypertension: a scoping review protocol
por: Arabadjian, Milla, et al.
Publicado: (2023)

Histopathology of the Mitral Valve Residual Leaflet in Obstructive Hypertrophic Cardiomyopathy
por: Troy, Aaron L., et al.
Publicado: (2023)

Indications for Surgery in Obstructive Hypertrophic Cardiomyopathy
por: Sherrid, Mark V.
Publicado: (2020)

Apical Ballooning and Cardiogenic Shock in Obstructive Hypertrophic Cardiomyopathy
por: Sherrid, Mark V., et al.
Publicado: (2018)

Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy
por: Sherrid, Mark V., et al.
Publicado: (2021)

Disease Expression and Outcomes in Black and White Adults With Hypertrophic Cardiomyopathy
por: Arabadjian, Milla E., et al.
Publicado: (2021)

Doppler Flow Patterns in HCM Patients With Apical Aneurysms Provide Insight Into Pathophysiology
por: Sherrid, Mark V., et al.
Publicado: (2023)

On-pump intracardiac echocardiography during septal myectomy for hypertrophic cardiomyopathy
por: Williams, David M., et al.
Publicado: (2020)

Drug Therapy for Hypertrophic Cardiomypathy: Physiology and Practice
por: V. Sherrid, Mark
Publicado: (2016)

Acquired pulmonary vein stenosis resulting in haemoptysis: a case series
por: Talmor, Nina, et al.
Publicado: (2021)

Blacks with Hypertrophic Cardiomyopathy Have Lower Quality of Life and Exercise Capacity Than Whites
por: Arabadjian, Milla E., et al.
Publicado: (2020)

Future Role of New Negative Inotropic Agents in the Era of Established Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy
por: Maron, Barry J., et al.
Publicado: (2022)

Hypertrophic cardiomyopathy masked by pericarditis
por: Nichols, Larry, et al.
Publicado: (2019)

Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy
por: Ho, Jennifer E, et al.
Publicado: (2017)

Hypertrophic cardiomyopathy in identical twins: a case series
por: Ashraf, Muddasir, et al.
Publicado: (2022)

The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy
por: Kittleson, Mark D, et al.
Publicado: (2021)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy: A Translational Study
por: Coppini, Raffaele, et al.
Publicado: (2019)

Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes
por: Ingles, Jodie, et al.
Publicado: (2019)

Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy
por: Farhad, Hoshang, et al.
Publicado: (2017)

Hypertrophic Obstructive Cardiomyopathy
por: Cohen, Lawrence S.
Publicado: (1972)

The genetics of hypertrophic cardiomyopathy
por: Akhtar, Mohammed, et al.
Publicado: (2018)

Disopyramide for Hypertrophic Cardiomyopathy
por: Sanchez-Nadales, Alejandro, et al.
Publicado: (2019)

Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy
por: Marston, Nicholas A, et al.
Publicado: (2021)

Major Clinical Issues in Hypertrophic Cardiomyopathy
por: Lee, Hyun-Jung, et al.
Publicado: (2022)

Infective endocarditis in obstructive hypertrophic cardiomyopathy: a case series and literature review
por: Wu, Zi-Wen, et al.
Publicado: (2021)

In vivo diffusion-weighted MRI detection of myocardial fibrosis in hypertrophic cardiomyopathy patients
por: Nguyen, Christopher T, et al.
Publicado: (2015)

High T2-weighted signal intensity is associated with myocardial deformation in hypertrophic cardiomyopathy
por: Shi, Ruo-yang, et al.
Publicado: (2019)

T2-weighted cardiac magnetic resonance image and myocardial biomarker in hypertrophic cardiomyopathy
por: Chen, Shi, et al.
Publicado: (2020)

Translational investigation of electrophysiology in hypertrophic cardiomyopathy
por: Flenner, Frederik, et al.
Publicado: (2021)

Pheochromocytoma and Hypertrophic Cardiomyopathy Leading to Cardiac Arrest
por: Niu, Kevyn, et al.
Publicado: (2023)

An Unusual Type of Hypertrophic Cardiomyopathy
por: Seo, Hye-Sun, et al.
Publicado: (2009)

Recent advances in hypertrophic cardiomyopathy
por: Yingchoncharoen, Teerapat, et al.
Publicado: (2014)

Diagnosis and management of hypertrophic cardiomyopathy
por: Pantazis, Antonis, et al.
Publicado: (2015)

Hypertrophic Cardiomyopathy: A Review
por: Houston, Brian A, et al.
Publicado: (2015)

Aortic biomechanics in hypertrophic cardiomyopathy
por: Badran, Hala Mahfouz, et al.
Publicado: (2015)

Ranolazine for Angina in Hypertrophic Cardiomyopathy
por: Amin, Akhtar, et al.
Publicado: (2018)

Neuromuscular diseases with hypertrophic cardiomyopathy
por: Cesar, Sergi
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qpmraruiapld6su2c2bcg21uhi